Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy DiaMedica Therapeutics stock | $7.41

Learn how to easily invest in DiaMedica Therapeutics stock.

DiaMedica Therapeutics Inc is a biotechnology business based in the US. DiaMedica Therapeutics shares (DMAC) are listed on the NASDAQ and all prices are listed in US Dollars. DiaMedica Therapeutics employs 10 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in DiaMedica Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DMAC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

DiaMedica Therapeutics stock price (NASDAQ: DMAC)

Use our graph to track the performance of DMAC stocks over time.

DiaMedica Therapeutics shares at a glance

Information last updated 2021-07-31.
Latest market close$7.41
52-week range$3.30 - $10.88
50-day moving average $5.32
200-day moving average $8.01
Wall St. target price$23.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.90

Buy DiaMedica Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy DiaMedica Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DiaMedica Therapeutics price performance over time

Historical closes compared with the close of $7.41 from 2021-05-28

1 week (2021-07-22) N/A
1 month (2021-07-02) 75.59%
3 months (2021-04-30) -21.17%
6 months (2021-01-29) N/A
1 year (2020-07-29) N/A
2 years (2019-07-29) N/A
3 years (2018-07-29) N/A
5 years (2016-07-29) N/A

DiaMedica Therapeutics financials

Gross profit TTM $0
Return on assets TTM -44.92%
Return on equity TTM -73.98%
Profit margin 0%
Book value $1.23
Market capitalisation $64.8 million

TTM: trailing 12 months

Shorting DiaMedica Therapeutics shares

There are currently 72,751 DiaMedica Therapeutics shares held short by investors – that's known as DiaMedica Therapeutics's "short interest". This figure is 47.6% down from 138,725 last month.

There are a few different ways that this level of interest in shorting DiaMedica Therapeutics shares can be evaluated.

DiaMedica Therapeutics's "short interest ratio" (SIR)

DiaMedica Therapeutics's "short interest ratio" (SIR) is the quantity of DiaMedica Therapeutics shares currently shorted divided by the average quantity of DiaMedica Therapeutics shares traded daily (recently around 559623.07692308). DiaMedica Therapeutics's SIR currently stands at 0.13. In other words for every 100,000 DiaMedica Therapeutics shares traded daily on the market, roughly 130 shares are currently held short.

However DiaMedica Therapeutics's short interest can also be evaluated against the total number of DiaMedica Therapeutics shares, or, against the total number of tradable DiaMedica Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DiaMedica Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 DiaMedica Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0042% of the tradable shares (for every 100,000 tradable DiaMedica Therapeutics shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DiaMedica Therapeutics.

Find out more about how you can short DiaMedica Therapeutics stock.

DiaMedica Therapeutics share dividends

We're not expecting DiaMedica Therapeutics to pay a dividend over the next 12 months.

Have DiaMedica Therapeutics's shares ever split?

DiaMedica Therapeutics's shares were split on a 1:20 basis on 14 November 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DiaMedica Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for DiaMedica Therapeutics shares which in turn could have impacted DiaMedica Therapeutics's share price.

DiaMedica Therapeutics share price volatility

Over the last 12 months, DiaMedica Therapeutics's shares have ranged in value from as little as $3.3 up to $10.88. A popular way to gauge a stock's volatility is its "beta".

DMAC.US volatility(beta: 2.39)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DiaMedica Therapeutics's is 2.3852. This would suggest that DiaMedica Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

DiaMedica Therapeutics overview

DiaMedica Therapeutics Inc. , a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase II REMEDY trials for the treatment of patients with acute ischemic stroke. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc.

Stocks similar to DiaMedica Therapeutics

Frequently asked questions

What percentage of DiaMedica Therapeutics is owned by insiders or institutions?
Currently 7.897% of DiaMedica Therapeutics shares are held by insiders and 33.296% by institutions.
How many people work for DiaMedica Therapeutics?
Latest data suggests 10 work at DiaMedica Therapeutics.
When does the fiscal year end for DiaMedica Therapeutics?
DiaMedica Therapeutics's fiscal year ends in December.
Where is DiaMedica Therapeutics based?
DiaMedica Therapeutics's address is: Two Carlson Parkway, Minneapolis, MN, United States, 55447
What is DiaMedica Therapeutics's ISIN number?
DiaMedica Therapeutics's international securities identification number is: CA25253X2077
What is DiaMedica Therapeutics's CUSIP number?
DiaMedica Therapeutics's Committee on Uniform Securities Identification Procedures number is: 25253X207

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site